A clinical trial to study the effect of Zinc sulfate in reducing the incidence of diarrhea, acute respiratory tract infections and in promoting growth in infants of 6-11 months of age.

Effect of prophylactic zinc supplementation on incidence of acute diarrhoea, respiratory tract infection and growth in infants of 6-11 months of age. - EPZDAG

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2010/091/001417

Enrollment

220

Registered

2010-11-01

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: zinc sulfate: 20mg/5ml per day for 14 days Control Intervention1: syrup base: 5ml/day for 14 days

Eligibility

Inclusion criteria

Inclusion criteria: The study would include apparently healthy infants of 6-11 months of age.

Exclusion criteria

Exclusion criteria: Recieving zinc supplement currently or in past 3 months; child who is severy malnourished, immunodeficient or on steroid therapy, severly ill requiring hospitalisation; and children of families who are not likely to stay in the study area till completion of the study

Design outcomes

Primary

Measure	Time frame
the incidence of diarrhoea, Acute respiratory tract infections and increase in height and weightTimepoint: 5 months	—

Secondary

Measure	Time frame
difference in duration of episodes of diarrhea and ARITimepoint: end of follow up period of 5 months	—

Countries

India

Contacts

Public ContactDr Akash Malik

davendrataneja@gmail.com09968604244

Outcome results